InsidersTradesSigma
Discover the complete record of transactions filed by Schafer Klaus, Director. Director active across 1 company, notably Altimmune, Inc.. Aggregated, 1 disclosures have been logged. Activity tracked since 20 June 2022. The latest transaction was filed on 20 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Klaus Schafer is a Board Member at Altimmune, Inc. He is involved in overseeing the company's operations and implementing its strategy. His expertise in the biopharmaceutical sector is a valuable asset for the organization.